These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37338525)

  • 1. Brain radiotherapy in patients treated for a newly diagnosed primary central nervous system lymphoma: professional practice evaluation in 19 French centers.
    Thomas-Joulié A; Houillier C; Antoni D; Créhange G; Jouglar E; Colin P; Benchalal M; Lang P; Alfonsi M; Hamidou H; Coutte A; Ahrweiller F; Dadoun N; Pointreau Y; Ammarguellat H; Bernier-Chastagner V; Belkacemi Y; Vieillot S; Hoang-Xuan K; Soussain C; Jacob J; Feuvret L
    Acta Oncol; 2023 Jun; 62(6):648-656. PubMed ID: 37338525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
    Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
    Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial.
    Thiel E; Korfel A; Martus P; Kanz L; Griesinger F; Rauch M; Röth A; Hertenstein B; von Toll T; Hundsberger T; Mergenthaler HG; Leithäuser M; Birnbaum T; Fischer L; Jahnke K; Herrlinger U; Plasswilm L; Nägele T; Pietsch T; Bamberg M; Weller M
    Lancet Oncol; 2010 Nov; 11(11):1036-47. PubMed ID: 20970380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A single-center, retrospective analysis of relapse and progression patterns of primary central nervous system lymphoma: can whole brain radiotherapy be replaced?].
    Qin Y; Liu R; Zhang X; Zhang W; Ren C; Wu D
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Apr; 43(4):499-506. PubMed ID: 37202184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective phase II trial of response adapted whole brain radiotherapy after high dose methotrexate based chemotherapy in patients with newly diagnosed primary central nervous system lymphoma-analysis of acute toxicity profile and early clinical outcome.
    Adhikari N; Biswas A; Gogia A; Sahoo RK; Garg A; Nehra A; Sharma MC; Bhasker S; Singh M; Sreenivas V; Chawla R; Joshi G; Kumar L; Chander S
    J Neurooncol; 2018 Aug; 139(1):153-166. PubMed ID: 29633112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relevance of intraocular involvement in the management of primary central nervous system lymphomas.
    Ferreri AJ; Blay JY; Reni M; Pasini F; Gubkin A; Tirelli U; Calderoni A; Zucca E; Cortelazzo S; Chassagne C; Tinguely M; Borisch B; Berger F; Ponzoni M; Cavalli F;
    Ann Oncol; 2002 Apr; 13(4):531-8. PubMed ID: 12056702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of whole-brain radiotherapy (WBRT) in primary central nervous system lymphoma: is it an alternative to ASCT for consolidation following HD-methotrexate based induction in low-income settings?
    de Pádua Covas Lage LA; Araújo Soares V; Meneguin TD; Culler HF; Reichert CO; Jacomassi MD; Reis DGC; Zerbini MCN; de Oliveira Costa R; Rocha V; Pereira J
    Radiat Oncol; 2022 Oct; 17(1):171. PubMed ID: 36273167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Retrospective Analysis of R-MPV Plus Response-adapted Whole-brain Radiotherapy for Elderly Patients with Primary Central Nervous System Lymphoma.
    Suzuki Y; Imoto N; Ishihara S; Fujiwara S; Ito R; Sakai T; Yamamoto S; Sugiura I; Kurahashi S
    Intern Med; 2022 May; 61(9):1345-1352. PubMed ID: 34670884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the Efficacy of DeVIC Therapy and High-dose Methotrexate Monotherapy with Whole-brain Radiation Therapy for Newly-diagnosed Primary Central Nervous System Lymphoma: A Single Institution Study.
    Chalise L; Motomura K; Ohka F; Hirano M; Hara M; Nishimura Y; Natsume A; Wakabayashi T
    Anticancer Res; 2017 Sep; 37(9):5215-5223. PubMed ID: 28870957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of radiation therapy in primary central nervous system lymphoma : KROG 14-20 Collaborative Study of Brain and Lymphoma Committee.
    Koh HK; Kim IH; Kim TM; Lim DH; Oh D; Cho JH; Kim WC; Kim JH; Chung WK; Jeong BK; Kang KM; Hong S; Suh CO; Kim IA
    J Neurooncol; 2017 Dec; 135(3):629-638. PubMed ID: 28939931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of additional radiotherapy for primary central nervous system lymphoma.
    Zacher J; Kasenda B; Engert A; Skoetz N
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD009211. PubMed ID: 24931518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous hematopoietic cell transplantation versus whole-brain radiotherapy consolidation in primary central nervous system lymphoma: A systematic review and meta-analysis.
    Epperla N; Reljic T; Chowdhury SM; Ferreri AJM; Kumar A; Hamadani M
    Hematol Oncol; 2023 Feb; 41(1):88-96. PubMed ID: 36192141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
    Illerhaus G; Marks R; Ihorst G; Guttenberger R; Ostertag C; Derigs G; Frickhofen N; Feuerhake F; Volk B; Finke J
    J Clin Oncol; 2006 Aug; 24(24):3865-70. PubMed ID: 16864853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary central nervous system lymphoma 1991-1997: outcome and late adverse effects after combined modality treatment.
    Herrlinger U; Schabet M; Brugger W; Kortmann RD; Kanz L; Bamberg M; Dichgans J; Weller M
    Cancer; 2001 Jan; 91(1):130-5. PubMed ID: 11148569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and outcome of primary CNS lymphoma in the modern era: An LOC network study.
    Houillier C; Soussain C; Ghesquières H; Soubeyran P; Chinot O; Taillandier L; Lamy T; Choquet S; Ahle G; Damaj G; Agapé P; Moluçon-Chabrot C; Amiel A; Delwail V; Fabbro M; Jardin F; Chauchet A; Moles-Moreau MP; Morschhauser F; Casasnovas O; Gressin R; Fornecker LM; Abraham J; Marolleau JP; Tempescul A; Campello C; Colin P; Tamburini J; Laribi K; Serrier C; Haioun C; Chebrek S; Schmitt A; Blonski M; Houot R; Boyle E; Bay JO; Oberic L; Tabouret E; Waultier A; Martin-Duverneuil N; Touitou V; Cassoux N; Kas A; Mokhtari K; Charlotte F; Alentorn A; Feuvret L; Le Garff-Tavernier M; Costopoulos M; Mathon B; Peyre M; Delgadillo D; Douzane H; Genet D; Aidaoui B; Hoang-Xuan K; Gyan E
    Neurology; 2020 Mar; 94(10):e1027-e1039. PubMed ID: 31907289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma.
    Shah GD; Yahalom J; Correa DD; Lai RK; Raizer JJ; Schiff D; LaRocca R; Grant B; DeAngelis LM; Abrey LE
    J Clin Oncol; 2007 Oct; 25(30):4730-5. PubMed ID: 17947720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balancing relapses versus cognitive impairment in primary central nervous system lymphoma: a single-center experience.
    Chanswangphuwana C; Rojnuckarin P; Cherdchoo N; Raiyawa T; Uaprasert N
    Hematology; 2018 Aug; 23(7):385-390. PubMed ID: 29256330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of radiotherapy in 1054 patients with primary central nervous system lymphoma treated from 1985 to 2009.
    Shibamoto Y; Sumi M; Takemoto M; Tsuchida E; Onodera S; Matsushita H; Sugie C; Tamaki Y; Onishi H
    Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):653-60. PubMed ID: 25034088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strong correlation between imaging response and survival among patients with primary central nervous system lymphoma: a secondary analysis of RTOG studies 83-15 and 88-06.
    Corn BW; Dolinskas C; Scott C; Donahue B; Schultz C; Nelson DF; Fisher B
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):299-303. PubMed ID: 10802352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced neurotoxicity with combined treatment of high-dose methotrexate, cyclophosphamide, doxorubicin, vincristine and prednisolone (M-CHOP) and deferred radiotherapy for primary central nervous system lymphoma.
    Ichikawa T; Kurozumi K; Michiue H; Ishida J; Maeda Y; Kondo E; Kawasaki A; Date I
    Clin Neurol Neurosurg; 2014 Dec; 127():106-11. PubMed ID: 25459253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.